NCT00940680View on ClinicalTrials.gov

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Hypertension
Interventions
DRUG

Amlodipine plus Losartan

amlodipine/losartan 5/100mg q.d.

DRUG

Losartan

losartan 100mg q.d.

Trial Locations (1)

Unknown

9 sites in Korea, Seoul, Daegu, Etc.

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT00940680 - Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension | Biotech Hunter | Biotech Hunter